Gemcitabine plus docetaxel (GD) versus capecitabine plus docetaxel (CD) for anthracycline-pretreated metastatic breast cancer (MBC) patients (pts): Results of a European phase III study.

被引：0
|
作者：
Chan, S
Romieu, G
Huober, J
Delozier, T
Tubiana-Hulin, M
Lluch, A
Schneeweiss, A
Llombart, A
Carrasco, E
Fumoleau, P
机构：
[1] City Hosp Nottingham, Nottingham, England
[2] Ctr Val Aurelle, Montpellier, France
[3] Univ Tubingen, Tubingen, Germany
[4] Ctr Francois Baclesse, F-14021 Caen, France
[5] Ctr Rene Huguenin, St Cloud, France
[6] Hosp Clin Univ, Valencia, Spain
[7] Univ Heidelberg, Heidelberg, Germany
[8] Inst Valencia Oncol, Valencia, Spain
[9] Eli Lilly & Co, Alcobendas, Spain
[10] Ctr Georges Francois Leclerc, Dijon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24S / 24S
页数：1
相关论文
共 50 条
  • [1] A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer
    Chan, S.
    Sharma, R.
    Romieu, G.
    Huober, T.
    Delozier, T.
    Tubiana-Hulin, M.
    Schneeweiss, A.
    Lluch, A.
    Llombart, A.
    du Bois, A.
    Carrasco, E.
    Thareau, A.
    Fumoleau, P.
    EJC SUPPLEMENTS, 2007, 5 (03): : 15 - 16
  • [2] Phase III study of gemcitabine plus docetaxel versus capecitabine plus docetaxel for anthracycline-pretreated metastatic breast cancer patients: survival results
    Chan, S.
    Romieu, G.
    Huober, J.
    Tubiana-Hulin, M.
    Schneeweiss, A.
    Lluch, A.
    Llombart, A.
    du Bois, A.
    Carrasco, E.
    Thareau, Vaury A.
    Fumoleau, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S68 - S68
  • [3] Gemcitabine plus docetaxel versus capecitabine plus docetaxel for patients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial
    Chan, S
    EJC SUPPLEMENTS, 2005, 3 (05): : 17 - 21
  • [4] Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer
    Chan, Stephen
    Romieu, Gilles
    Huober, Jens
    Delozier, Thierry
    Tubiana-Hulin, Michele
    Schneeweiss, Andreas
    Lluch, Ana
    Llombart, Antonio
    du Bois, Andreas
    Kreienberg, Rolf
    Mayordomo, Jose Ignacio
    Anton, Antonio
    Harrison, Mark
    Jones, Alison
    Carrasco, Eva
    Vaury, A. Thareau
    Frimodt-Moller, Bente
    Fumoleau, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1753 - 1760
  • [5] A randomized controlled Phase II trial of vinorelbine plus capecitabine versus docetaxel plus capecitabine in anthracycline-pretreated women with metastatic breast cancer
    Li, Shufen
    Meng, Wenjing
    Zhang, Jibo
    Xie, Xiaojuan
    Hao, Chunfang
    Jia, Yongsheng
    Tong, Zhongsheng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (05) : 1069 - 1076
  • [6] Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC)
    Seidman, A. D.
    Brufsky, A.
    Ansari, R. H.
    Rubinsak, J. R.
    Stein, R. S.
    Schwartzberg, L. S.
    Stewart, J. F.
    Zhao, L.
    Gill, J.
    Tai, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : CP48 - U410
  • [7] Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results
    O'Shaughnessy, J
    Miles, D
    Vukelja, S
    Moiseyenko, V
    Ayoub, JP
    Cervantes, G
    Fumoleau, P
    Jones, S
    Lui, WY
    Mauriac, L
    Twelves, C
    Van Hazel, G
    Verma, S
    Leonard, R
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2812 - 2823
  • [8] A Pooled Analysis of Gemcitabine Plus Docetaxel Versus Capecitabine Plus Docetaxel in Metastatic Breast Cancer
    Seidman, Andrew D.
    Chan, Stephen
    Wang, Jin
    Zhu, Chao
    Xu, Cong
    Xu, Binghe
    ONCOLOGIST, 2014, 19 (05): : 443 - 452
  • [9] Docetaxel toxicity and activity in anthracycline-pretreated metastatic breast cancer (MBC)
    Milella, M
    Vaccaro, A
    Ferraresi, V
    D'Ottavio, AM
    Papaldo, P
    Nisticò, C
    Marsella, A
    Thorel, MF
    Carpino, A
    Cercato, MC
    Terzoli, E
    Cognetti, F
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S42 - S42
  • [10] Gemcitabine plus docetaxel versus docetaxel in patients (pts) with HER2-negative locally advanced or metastatic breast cancer (MBC): A randomized phase III study
    Nielsen, D. L.
    Langkjer, S. T.
    Bjerre, K.
    Cold, S.
    Stenbygaard, L.
    Soerensen, P. G.
    Kamby, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345